News & Perspective

Jun 10, 2005

Jun 10, 2005

Foreign Affairs focuses on pandemic threat

(CIDRAP News) – The influential journal Foreign Affairs is adding its voice to the warnings about a potential influenza pandemic by publishing a special section on pandemics in its forthcoming July/August issue.

Oct 25, 2007

Oct 25, 2007

THE PANDEMIC VACCINE PUZZLE Part 1: Flu research: a legacy of neglect

Editor's note: This is the first in a seven-part series investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Dec 14, 2007

Dec 14, 2007

Players in H5N1's debut ponder a decade's lessons

(CIDRAP News) – Dr. Keiji Fukuda still remembers the intense emotions that tumbled through his mind as he waited to board his hastily scheduled flight out of Atlanta. His destination was Asia. In Hong Kong, a newly identified avian influenza virus, recently dubbed H5N1, was making people desperately ill.

Aug 25, 2008

Aug 25, 2008

H1N1 flu viruses growing more resistant to Tamiflu

(CIDRAP News) – With influenza season well under way in the southern hemisphere, one of the three kinds of seasonal influenza virus is becoming increasingly resistant to the antiviral drug oseltamivir (Tamiflu), the World Health Organization (WHO) reported last week.

Sep 05, 2008

Sep 05, 2008

Dutch patient dies from Tamiflu-resistant H1N1 virus

(CIDRAP News) – Amid concern about rising resistance to oseltamivir (Tamiflu) in influenza A/H1N1 viruses, a Dutch team this week reported the death of a leukemia patient who was infected with an H1N1 virus that was resistant to the antiviral drug.

Feb 03, 2009

Feb 03, 2009

Experts weigh new H5N1 vaccine strategies

(CIDRAP News) – At an Infectious Diseases Society of America (IDSA) symposium in Washington, DC, today on seasonal and pandemic influenza, a group of experts fielded questions from reporters on some of the new trends and emerging issues, including prepandemic strategies for H5N1 avian influenza vaccines, now that some countries are stockpiling them.

Mar 02, 2009

Mar 02, 2009

H1N1 viruses gain Tamiflu resistance without losing fitness

(CIDRAP News) – Studies published today confirm that influenza A/H1N1 viruses have become widely resistant to oseltamivir (Tamiflu), the leading flu drug, without losing their ability to make people sick—thereby underlining the need for new antiviral drugs.

Apr 23, 2009

Apr 23, 2009

More US swine flu cases, Mexico illnesses raise pandemic questions

(CIDRAP News) – Five more cases of an unusual swine influenza virus infection have surfaced, officials from the US Centers for Disease Control and Prevention (CDC) announced today, bringing the total to seven and raising more concerns about human-to-human transmission.

Apr 24, 2009

Apr 24, 2009

Labs confirm same swine flu in deadly Mexican outbreaks

(CIDRAP News) – Samples from a deadly respiratory illness outbreak in Mexico match swine influenza isolates from patients in the United States who had milder illnesses, an official from the US Centers for Disease Control and Prevention (CDC) said today, fueling speculation that the World Health Organization (WHO) could be on the verge of raising the global pandemic alert level.

Pages

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»